Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Natural Health Trends Expects Q1 Revenue Growth Of 75%

4/13/2012 4:28 PM ET

Natural Health Trends Corp. (NHTC.OB) said that its estimated revenue for the quarter ended March 31, 2012 was $9.1 million, a 75 percent growth compared to last year.

The company also estimates that its deferred revenue, consisting of unshipped product and unamortized enrollment fees, at March 31, 2012 was $1.3 million, compared to $967 thousands at December 31, 2011.

Click here to receive FREE breaking news email alerts for Natural Health Trends Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Thailand lowered its full-year growth outlook after weaker domestic demand and exports weighed on economic activity in the first three months of the year. Gross domestic product expanded 5.3 percent year-on-year in the first quarter of 2013 compared to an upwardly revised 19.1 percent growth in the fourth quarter of 2012, the National Economic and Social Development Board (NESDB) said Monday. The fifth consecutive monthly increase in the U.K. house prices amid limited supply took average asking prices to a record, a survey by Rightmove showed Monday. House prices hit a record GBP 249,841 in May, as new sellers raised their prices by 2.1 percent from the prior month. Prices were up by the same magniture in April. The Japanese government on Monday upgraded its assessment of the economy for the first time in two months, as a weak yen helped revive the country's exports and factory output. "The Japanese economy is picking up slowly," the Cabinet Office said in its May monthly report. This was an upgrade from previous month's assessment when it said that economy was showing signs of picking up.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.